Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Citi
McKinsey
Novartis
Fish and Richardson
US Department of Justice
Federal Trade Commission
Julphar
Healthtrust
Daiichi Sankyo

Generated: August 16, 2017

DrugPatentWatch Database Preview

ALENDRONATE SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Alendronate Sodium, and when can generic versions of Alendronate Sodium launch?

Alendronate Sodium is a drug marketed by Impax Labs Inc, West-ward Pharms Int, Sun Pharma Global, Aurobindo Pharma, Mylan, Dr Reddys Labs Ltd, Jubilant Cadista, Austarpharma Llc, Cipla Ltd, Upsher-smith Labs, Apotex, Teva Pharms, and Watson Labs. and is included in fourteen NDAs.

The generic ingredient in ALENDRONATE SODIUM is alendronate sodium. There are twenty-five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.

Summary for Tradename: ALENDRONATE SODIUM

Patents:0
Applicants:13
NDAs:14
Suppliers / Packagers: see list28
Bulk Api Vendors: see list127
Clinical Trials: see list2,493
Patent Applications: see list4,882
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALENDRONATE SODIUM at DailyMed

Pharmacology for Tradename: ALENDRONATE SODIUM

Ingredient-typeDiphosphonates
Drug ClassBisphosphonate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex
ALENDRONATE SODIUM
alendronate sodium
TABLET;ORAL077982-004Aug 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
ALENDRONATE SODIUM
alendronate sodium
TABLET;ORAL076768-005Aug 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ALENDRONATE SODIUM
alendronate sodium
TABLET;ORAL076984-002Aug 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
ALENDRONATE SODIUM
alendronate sodium
TABLET;ORAL076584-004Aug 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ALENDRONATE SODIUM
alendronate sodium
TABLET;ORAL076984-003Aug 4, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Queensland Health
Fuji
Daiichi Sankyo
Harvard Business School
Express Scripts
Healthtrust
Merck
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot